PRNewsWire - Health

FDA approves Gamifant® (emapalumab-lzsg) as first-ever treatment for adults and children with Macrophage Activation Syndrome in Still's disease
HEPA Filters Market to Reach $5.8 Billion by 2032, Growing at a CAGR of 7.9% from 2025, Says Meticulous Research®
Freeze Drying Equipment Market to Surge from USD 4.9 Billion to USD 8.4 Billion by 2032 - Meticulous Research®
Texas Centers for Infectious Disease Associates Notifies Individuals of Data Security Incident